Trials / Completed
CompletedNCT06052319
A Study to Assess the Engagement and Usefulness of Care4Today Digital Platform for Disease Management in Coronary Artery Disease (CAD) and/or Peripheral Artery Disease (PAD) Population
A Pilot Study to Assess the Engagement and Usefulness of Care4Today Digital Platform for Disease Management in Coronary Artery Disease/ Peripheral Artery Disease (CAD/PAD) Population
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 277 (actual)
- Sponsor
- Janssen Scientific Affairs, LLC · Industry
- Sex
- All
- Age
- 40 Years – 90 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to assess the engagement and usefulness of Care4Today® Connect CAD-PAD digital platform in participants with coronary artery disease or peripheral artery disease (CAD or PAD).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Care4Today® Connect CAD-PAD Mobile Application | Participants will not receive any drug intervention in this study. Participants will use Care 4Today® Connect CAD-PAD mobile application for 3 months. The study will assess participant engagement and usefulness. |
Timeline
- Start date
- 2023-11-29
- Primary completion
- 2024-08-13
- Completion
- 2024-08-13
- First posted
- 2023-09-25
- Last updated
- 2025-04-27
Locations
6 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT06052319. Inclusion in this directory is not an endorsement.